Exponent (EXPO) saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 69 to 74.
When looking for the best stocks to buy and watch, be sure to pay attention to relative price strength.
This unique rating measures market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock’s price performance over the trailing 52 weeks matched up against all other stocks.
History reveals that the best-performing stocks often have an RS Rating of over 80 as they launch their largest climbs. See if Exponent can continue to show renewed price strength and clear that threshold.
See How IBD Helps You Make More Money In Stocks
Exponent is working on a cup without handle with a 127.71 entry. See if the stock can clear the breakout price in volume at least 40% above average.
Exponent posted 6% EPS growth in the latest quarterly report. Revenue increased 10%. Look for the next report on or around Apr. 29.
The company holds the No. 4 rank among its peers in the Commercial Services-Consulting industry group. Resources Connection (RGP) and Leidos (LDOS) are also among the group’s highest-rated stocks.
Get exclusive IBD analysis and actionable news daily.
Please enter a valid email address
Please select a newsletter
You will now receive IBD Newsletters
Something Went Wrong!
Please contact customer service
YOU MIGHT ALSO LIKE:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD’s Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Identify Bases And Buy Points With Pattern Recognition From MarketSmith